These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 17230481)
1. Association between parasite infection and immune responses in multiple sclerosis. Correale J; Farez M Ann Neurol; 2007 Feb; 61(2):97-108. PubMed ID: 17230481 [TBL] [Abstract][Full Text] [Related]
2. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. Carrier Y; Yuan J; Kuchroo VK; Weiner HL J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782 [TBL] [Abstract][Full Text] [Related]
4. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400 [TBL] [Abstract][Full Text] [Related]
5. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis. Han D; Wang C; Lou W; Gu Y; Wang Y; Zhang L Clin Immunol; 2010 Aug; 136(2):292-301. PubMed ID: 20403730 [TBL] [Abstract][Full Text] [Related]
6. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115 [TBL] [Abstract][Full Text] [Related]
7. Decreased suppression of CD8 Giri PS; Dwivedi M; Begum R Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346 [TBL] [Abstract][Full Text] [Related]
8. Loss of regulatory characteristics in CD4 Bian LQ; Mao L; Bi Y; Zhou SW; Chen ZD; Wen J; Shi J; Wang L APMIS; 2017 Dec; 125(12):1108-1116. PubMed ID: 28913840 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients. Wing AC; Hygino J; Ferreira TB; Kasahara TM; Barros PO; Sacramento PM; Andrade RM; Camargo S; Rueda F; Alves-Leon SV; Vasconcelos CC; Alvarenga R; Bento CA Immunology; 2016 Feb; 147(2):212-20. PubMed ID: 26781085 [TBL] [Abstract][Full Text] [Related]
10. [Effect of human bone marrow mesenchymal stem cells on allogeneic regulatory T cells and its possible mechanism]. Yang J; Wang QH; Zeng QT; Mao XB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):785-9. PubMed ID: 17708804 [TBL] [Abstract][Full Text] [Related]
11. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related]
12. Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer. Hoffman BE; Martino AT; Sack BK; Cao O; Liao G; Terhorst C; Herzog RW Mol Ther; 2011 Jul; 19(7):1263-72. PubMed ID: 21386826 [TBL] [Abstract][Full Text] [Related]
13. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326 [TBL] [Abstract][Full Text] [Related]
14. Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression. Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM J Neuroimmunol; 2003 Aug; 141(1-2):132-40. PubMed ID: 12965264 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of antigen-specific CD4+CD25+ regulatory T cells from autologous naïve CD4+ T cells of multiple sclerosis patients as a potential therapeutic approach. Xiang YJ; Ren M; Jiang H; Yang TT; He Y; Ao DH; Wang YY; Zhang Q; He XJ; Gao XG; Liu GZ Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5261-5270. PubMed ID: 28051239 [TBL] [Abstract][Full Text] [Related]
16. Determination of a CD4 Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059 [TBL] [Abstract][Full Text] [Related]
18. Factors of Suppression of Immune Response in Patients with Pulmonary Tuberculosis and Eosinophilia. Urazova OI; Novitskii VV; Kolobovnikova YV; Churina EG Bull Exp Biol Med; 2015 Jul; 159(3):323-6. PubMed ID: 26212806 [TBL] [Abstract][Full Text] [Related]
19. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines. Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055 [TBL] [Abstract][Full Text] [Related]
20. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]